ECOG-ACRIN logo[19516]275x75ECOG-ACRIN logo[19516]275x75ECOG-ACRIN logo[19516]275x75ECOG-ACRIN logo[19516]275x75
  • Home
  • Archive
  • Contact

Blog

  • Home
  • Blog

A blog to share information with our members, staff, and the cancer research community

Categories

  • From the Co-Chairs
  • Active Clinical Trials
  • Institution Spotlights
  • Special Topics
  • People
  • News in Brief
  • Trial Results

Recent Issues

  • ►2022 (7)
    • ▼January (7)
      • From the Co-Chairs, January 2022
      • Now Enrolling: EA3202 for Head and Neck Squamous Cell Carcinoma
      • Come Again? Communicating Clearly About Risk of Recurrence After Early-Stage Breast Cancer
      • Trial Spotlight: Jarushka Naidoo on the EAQ172 Trial for Steroid-Refractory Pneumonitis
      • Institution Spotlight: Georgia NCORP
      • Trial Results: Journal of Clinical Oncology Publishes Final Results of E3311 Phase II Trial for Head and Neck Cancer
      • News in Brief, January 2022
  • ►2021 (72)
    • ►December (6)
    • ►November (8)
    • ►October (7)
    • ►September (7)
    • ►August (7)
    • ►July (8)
    • ►May (7)
    • ►April (5)
    • ►March (6)
    • ►February (5)
    • ►January (6)
  • ►2020 (55)
    • ►December (5)
    • ►October (7)
    • ►September (5)
    • ►July (7)
    • ►June (6)
    • ►May (7)
    • ►April (7)
    • ►February (5)
    • ►January (6)
  • ►2019 (6)
    • ►November (6)
  • Active ECOG-ACRIN Trials
  • ECOG-ACRIN.org

Tags

Acute myeloid leukemia Advocacy Big data Breast cancer Cancer Cancer care delivery research Cancer screening Cancer surveillance Chronic lymphocytic leukemia Comis symposium Communication COVID-19 De-escalation Diversity Ethics GI cancer Group meeting Head and neck cancer Head and neck squamous cell carcinoma Health equity Immunotherapy Leukemia Lung cancer Lymphoma Melanoma Mentorship Multiple myeloma Myeloma NCI-MATCH NCORP Non-small cell lung cancer Pancreatic cancer Pancreatic cyst Personalized screening Pneumonitis Precision medicine Prevention Prostate cancer Radiology Reproductive health Social determinants of health Survivorship Targeted therapy TMIST Vaccination
STAY UP TO DATE

Opt in to ensure we deliver this monthly blog directly to your inbox. We will never share your email.

Select list(s) to subscribe to

By submitting this form, you are consenting to receive marketing emails from: ECOG-ACRIN Cancer Research Group, 1818 Market Street, Philadelphia, PA, 19103, http://ecog-acrin.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2021 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc